Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable
Image File
Original HTML

Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable

CAMBRIDGE, England, Oct. 6, 2026 /PRNewswire/ -- Cambridge Heartwear® Limited (www.camheartwear.com) has secured a landmark £184 million tender with the National Health Service (NHS) of the UK for HeartSense®, the world's first medical-grade, multi-channel, portable, wirelessly charged ECG wearable straight to one's mobile phone, representing a significant advancement in global Medical technology, AI application and cardiovascular diagnostics.

The agreement with the UK National Health Service Supply chain enables the deployment of advanced cardiac monitoring technology across primary and secondary care and civil service departments, empowering patients to diagnose heart rhythm problems whenever and wherever they are to prevent heart failure and strokes earlier, reduce waiting times and support a more preventative approach to Heart Disease, which can take place in the comfort of their own homes.

HeartSense® is the world's first wearable to combine diagnostic-grade multi-channel ECG monitoring, adaptive artificial intelligence and wireless charging in a single device. Manufactured to bridge the gap in women's cardiovascular care with its ergonomic design, the technology gives healthcare professionals and patients access to continuous, real-time ECG data on a mobile phone. giving you back the control of your health at every stage.

Engineered in Cambridge and manufactured in Britain, HeartSense® has been developed to help identify cardiovascular disease and stroke risk before conditions become acute. Its proprietary engineering and AI technology with (86 patents ) support earlier intervention, enabling clinicians to make more informed decisions and improve patient outcomes.

The system is UKCA approved and ISO 13845 certified, with FDA 510(k) applications currently in progress.

"We did not have a UK ECG manufacturer and reporter until now," said Professor Rameen Shakur, Founder of Cambridge Heartwear. "HeartSense® is the world's first medical-grade, AI-powered, multi-channel ECG wearable and demonstrates what can be achieved when clinicians, engineers and AI specialists work together. We want to help move healthcare towards earlier diagnosis, better prevention and improved outcomes for patients across the NHS."

The partnership with the NHS Supply Chain allows Integrated Care Boards to deploy HeartSense® at scale, supporting the delivery of diagnostic-quality heart monitoring beyond hospital environments. The initiative is intended to reduce pressure on secondary care services while improving access to high-quality cardiac diagnostics in community settings.

Founded by Professor Rameen Shakur, Cambridge Heartwear is a medical technology company based at Cambridge Science Park coming out of the University of Cambridge dedicated to making heart health monitoring simple, accessible and accurate. Combining medical research, engineering excellence and artificial intelligence, the company develops advanced wearable technologies that empower patients and healthcare professionals with diagnostic-quality cardiovascular insights anytime, anywhere. HeartSense® helps detect heart conditions earlier, enabling more informed clinical decision-making and better patient care.

Contact: [email protected]

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Need Review
Dedupe hash
prn_302900084
Press Eligible
Yes
Press Eligible Reason
QA FAIL (need review): Final paragraph is boilerplate corporate background (location/origin) with no news context, rather than ending with substantive news information.
Source Name
Unknown Company
Original Summary

<p>CAMBRIDGE, England, Oct. 6, 2026 /PRNewswire/ -- Cambridge Heartwear® Limited (www.camheartwear.com) has secured a landmark £184 million tender with the National Health Service (NHS) of the UK for HeartSense®, the world's first medical-grade, multi-channel, portable, wirelessly charged...</p>

Original Link
Original Source
Image URL
https://mmx.prnewswire.com/media/MS2001794/Screenshot-2026-10-02-at-21-21-34.jpg?id=OA2985401&p=facebook
Generated Article_json
{"target_audience": "b2b", "is_medical": true, "ai_generated_title": "Cambridge Heartwear Wins £184M NHS Deal for ECG Wearable", "body_html": "<p><strong>Cambridge, England -- [CURRENT_DATE] --</strong> Cambridge Heartwear Limited has secured a £184 million tender with the UK National Health Service for HeartSense, a medical-grade, multi-channel ECG wearable that charges wirelessly and streams diagnostic data directly to a mobile phone.</p><p><h5>NHS Supply Chain deal enables nationwide rollout of cardiac wearable</h5></p><p>The agreement with NHS Supply Chain allows Integrated Care Boards to deploy HeartSense across primary and secondary care settings and civil service departments. The device is designed to let patients monitor heart rhythm at home, with the stated aim of catching arrhythmia, heart failure risk and stroke risk earlier while reducing pressure on hospital waiting lists.</p><p><h5>Device combines multi-channel ECG, AI and wireless charging in one unit</h5></p><p>Cambridge Heartwear describes HeartSense as the first wearable to combine diagnostic-grade multi-channel ECG monitoring, adaptive artificial intelligence and wireless charging in a single device. The company says the ergonomic design was engineered to address gaps in women's cardiovascular care, giving clinicians and patients continuous real-time ECG data via smartphone.</p><p><h5>Technology is backed by 86 patents and built on UK manufacturing base</h5></p><p>Engineered in Cambridge and manufactured in Britain, HeartSense is supported by a portfolio of 86 patents covering its proprietary engineering and AI technology. The system holds UKCA approval and ISO 13845 certification, and the company has FDA 510(k) applications currently in progress for U.S. market entry.</p><p><h5>Founder says device fills gap left by absence of UK ECG manufacturer</h5></p><p>Professor Rameen Shakur, founder of Cambridge Heartwear, said the UK previously lacked a domestic ECG manufacturer and reporter. He said HeartSense was built by combining clinicians, engineers and AI specialists to push healthcare toward earlier diagnosis and prevention across the NHS.</p><p>Cambridge Heartwear operates out of Cambridge Science Park and originated from the University of Cambridge.</p>", "meta_description": "Cambridge Heartwear wins £184M NHS tender for HeartSense, a wireless multi-channel ECG wearable with 86 patents and FDA review underway.", "seo_keywords": "Cambridge Heartwear, HeartSense, NHS tender, ECG wearable, cardiac monitoring, medical device, UKCA approval, FDA 510k", "companies": ["Cambridge Heartwear"], "industries": ["Healthcare & Biotech"], "markets_regions": ["United Kingdom"], "news_type": ["financial_disclosure", "product_launch"], "themes": ["regulatory_compliance", "digital_transformation"], "products": ["HeartSense"], "events": [], "cta_text": "Details on the NHS Supply Chain tender and HeartSense deployment are available from Cambridge Heartwear.", "learn_more": "https://www.camheartwear.com", "fact_check": {"accuracy_score": 100, "legal_risk": "low", "corrections_made": [], "recommendation": "publish"}}
Content Hash (SHA-256, erste 32 hex)
99fa7bed1aa7f6762d4cb7c6b1daecf1